… Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA … /news-stories/nubeqa-prostate-cancer-research.

Bayer will present new data for NUBEQA® (darolutamide) in prostate cancer at the upcoming American Urological Association (AUA) Annual Meeting taking place in Las Vegas from April 26-29, 2025. These data support the potential of NUBEQA as a treatment …

… , April 10, the 2025 Prostate Cancer Research Gala was held at the … continue contributing to support the Prostate Cancer Research Program  by visiting  – giving. … technology, set new standards in prostate cancer research, and provide every patient with …

The abundant potential arising from various applications of artificial intelligence is gradually influencing academic and scientific communication. This study examines the suitability of ChatGPT‑4 for generating layperson's summaries (LS) of scientific …

… awareness and vital funds for prostate cancer research and testing, a charity match …

… programme Rishi Sunak has joined Prostate Cancer Research as an ambassador to champion … to become an ambassador for Prostate Cancer Research and support the charity’s … my work as ambassador for Prostate Cancer Research will encourage more men to …

… 2025 Courtesy Story The Prostate Cancer Research Program recognizes that investigators … which focused on expanding prostate cancer research capacity: Early Investigator Research … make significant contributions to prostate cancer research and patient care, and …

Doctors, cancer survivors and local celebrities modeled blue jackets to highlight the importance of early cancer detection. ST. LOUIS — On Sunday night, a local organization used fashion to raise awareness for prostate cancer. Gent Men's Fashion Week …

Prostate cancer (PCa) ranks as the second most common disease among men and the fourth most prevalent cancer worldwide. Enhanced glycolysis and excessive lactate secretion are recognized as critical factors driving the progression of various cancers. This …

Award follows extensive pre-clinical, single agent activity data generated by Prof. Colleen Nelson’s lab at QUT in ‘Aggressive Variant’ prostate cancer models CAMBRIDGE, MA, UNITED STATES, January 9, 2025 /⁨EINPresswire.com⁩/ -- Cambridge, MA (USA …